Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer

Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer

Abstract The evolutionary dynamics of tumor‐associated neoantigens carry information about drug sensitivity and resistance to the immune checkpoint blockade (ICB). However, the spectrum of somatic mutations is highly heterogeneous among patients, making it difficult to track neoantigens by circulati...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Qingzhu Jia, Luting Chiu, Shuangxiu Wu, Jian Bai, Lina Peng, Linpeng Zheng, Rui Zang, Xueqin Li, Bibo Yuan, Yixing Gao, Dingyong Wu, Xiaohong Li, Lin Wu, Jianguo Sun, Ji He, Bruce W. S. Robinson, Bo Zhu
Materialtyp:	Artikel
Språk:	English
Publicerad:	Wiley 2020-05-01
Serie:	Advanced Science
Ämnen:	ctDNA sequencing immune checkpoint blockade neoantigens non‐small cell lung cancer personalized medicine
Länkar:	https://doi.org/10.1002/advs.201903410

Liknande verk

Progress in Neoantigen Targeted Cancer Immunotherapies
av: Xue-Jiao Han, et al.
Publicerad: (2020-07-01)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
av: Kim Bich Nguyen, et al.
Publicerad: (2023-08-01)

Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
av: Hui Peng, et al.
Publicerad: (2022-12-01)

Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity
av: Fanqiang Meng, et al.
Publicerad: (2022-12-01)

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
av: Da Zhang, et al.
Publicerad: (2021-03-01)

Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1
av: Di Wu, et al.
Publicerad: (2020-07-01)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
av: Xue-lin Zou, et al.
Publicerad: (2021-12-01)

Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies
av: Binghan Zhou, et al.
Publicerad: (2021-06-01)

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
av: Kellie N. Smith, et al.
Publicerad: (2019-02-01)

A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance
av: Ginette S. Santiago-Sánchez, et al.
Publicerad: (2024-12-01)

Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes
av: Rene van Tienhoven, et al.
Publicerad: (2024-03-01)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
av: Zhi Pang, et al.
Publicerad: (2023-12-01)

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
av: Zijun Y. Xu-Monette, et al.
Publicerad: (2019-10-01)

The Value of Microbes in Cancer Neoantigen Immunotherapy
av: Junrui Tian, et al.
Publicerad: (2023-08-01)

Tumor neoantigens: from basic research to clinical applications
av: Tao Jiang, et al.
Publicerad: (2019-09-01)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
av: Na Zhang, et al.
Publicerad: (2020-11-01)

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
av: Eric Bartee, et al.
Publicerad: (2017-05-01)

Combining photothermal ablation-based vaccine with immune checkpoint blockade for synergistic osteosarcoma immunotherapy
av: Xingyu Zhao, et al.
Publicerad: (2021-01-01)

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
av: Irantzu Anzar, et al.
Publicerad: (2023-09-01)

Regulatory T cells in immune checkpoint blockade antitumor therapy
av: An Zhang, et al.
Publicerad: (2024-11-01)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
av: Zhijia Xia, et al.
Publicerad: (2023-07-01)

Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
av: Tietze Stefanie, et al.
Publicerad: (2021-04-01)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
av: Lin X, et al.
Publicerad: (2021-03-01)

Tumor neoantigens and tumor immunotherapies
av: Wang Jiani, et al.
Publicerad: (2024-04-01)

Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
av: Hyungjoo Kim, et al.
Publicerad: (2022-05-01)

Neoantigens: new hope for cancer therapy
av: Yitong Hu, et al.
Publicerad: (2025-03-01)

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
av: Yanna Lei, et al.
Publicerad: (2021-03-01)

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
av: Jiawei Shou, et al.
Publicerad: (2022-09-01)

Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy
av: Christopher C. T. Sng, et al.
Publicerad: (2024-03-01)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
av: Yicheng Zhu, et al.
Publicerad: (2021-06-01)

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
av: Zhiyang Huang, et al.
Publicerad: (2025-02-01)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
av: Florent Petitprez, et al.
Publicerad: (2020-05-01)

Overcoming melanoma resistance to immune checkpoint blockade therapy using nano-strategies
av: Yiqin Ding, et al.
Publicerad: (2023-12-01)

Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
av: Qingqing Xiao, et al.
Publicerad: (2023-08-01)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
av: Roberta Zappasodi, et al.
Publicerad: (2022-12-01)

Current Trends in Neoantigen-Based Cancer Vaccines
av: Szu-Ying Ho, et al.
Publicerad: (2023-03-01)

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response
av: Jingjing Li, et al.
Publicerad: (2020-08-01)

Neoantigen immunotherapy: a novel treatment for bladder cancer
av: Ruiyang Lv, et al.
Publicerad: (2025-01-01)

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens
av: Luhui Shen, et al.
Publicerad: (2023-05-01)

Targeting neoantigens for cancer immunotherapy
av: Xuan Zhao, et al.
Publicerad: (2021-07-01)